The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overcoming therapeutic failure in osteosarcoma via Apatinib-encapsulated hydrophobic poly(ester amide) nanoparticles
Abstract
A nano-Apatinib delivery system overcomes drug resistance by targeting osteosarcoma stem-like cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Li et al. treated late-stage osteosarcoma using apatinib enclosed in hydrophobic poly[ester amide] nanoparticles, which notably inhibited tumor proliferation with minimal adverse effects [276].”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [276]
Citations
Cites
Xie, L., Xu, J., Sun, X., Tang, X., Yan, T., Yang, R., & Guo, W. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0542 · Cited by 128
Research works printed but not linked: 43
- Gambera, 2018, Nat. Commun., 9, 3994, 10.1038/s41467-018-06401-z · DOI
- Zhang, 2020, J. Orthop. Surg. Res., 15, 51, 10.1186/s13018-020-1576-0 · DOI
- Wang, 2017, J. Biomed. Nanotechnol., 13, 911, 10.1166/jbn.2017.2396 · DOI
- Zhou, 2016, Biomater. Sci., 4, 1212, 10.1039/C6BM00331A · DOI
- Song, 2019, Chin. Chem. Lett., 30, 1038, 10.1016/j.cclet.2019.02.017 · DOI
- Du, 2019, Biomater. Sci., 7, 1147, 10.1039/C8BM01350K · DOI
- Geller, 2018, Cancer, 124, 4548, 10.1002/cncr.31725 · DOI
- Duffaud, 2020, Curr. Treat. Options Oncol., 21, 65, 10.1007/s11864-020-00760-w · DOI
- Liu, 2011, Chin. Chem. Lett., 22, 757, 10.1016/j.cclet.2010.12.043 · DOI
- Lu, 2019, Asian J. Pharm. Sci., 14, 595, 10.1016/j.ajps.2019.04.004 · DOI
- Yao, 2019, Arch. Med. Res., 50, 47, 10.1016/j.arcmed.2019.03.002 · DOI
- Grignani, 2015, Lancet Oncol., 16, 98, 10.1016/S1470-2045(14)71136-2 · DOI
- Xie, 2017, Oncol. Rep., 38, 625, 10.3892/or.2017.5735 · DOI
- Wang, 2019, Biomater. Sci., 7, 4218, 10.1039/C9BM00907H · DOI
- Gao, 2016, Chin. Chem. Lett., 27, 200, 10.1016/j.cclet.2015.10.004 · DOI
- Chen, 2019, Ann. Transl. Med., 7, 181, 10.21037/atm.2019.03.68 · DOI
- Geng, 2018, Expert Opin. Drug Saf., 17, 1145, 10.1080/14740338.2018.1535592 · DOI
- Zhao, 2018, OncoTargets Ther., 11, 4137, 10.2147/OTT.S172305 · DOI
- Li, 2019, Biomater. Sci., 7, 1584, 10.1039/C8BM01337C · DOI
- Xie, 2018, BMC Cancer, 18, 396, 10.1186/s12885-018-4303-z · DOI
- Yang, 2020, Angiogenesis, 23, 279, 10.1007/s10456-020-09716-y · DOI
- Hu, 2019, J. Biomed. Nanotechnol., 15, 1256, 10.1166/jbn.2019.2770 · DOI
- Tian, 2020, Invest. New Drugs, 38, 1559, 10.1007/s10637-020-00912-7 · DOI
- Takahashi, 2019, Cancer Res., 79, 3088, 10.1158/0008-5472.CAN-18-2693 · DOI
- Liang, 2019, Stem Cells Int., 2019, 7028901, 10.1155/2019/7028901 · DOI
- Zhang, 2019, Drug Des., Dev. Ther., 13, 4075, 10.2147/DDDT.S224312 · DOI
- Subramaniam, 2020, Cell Death Dis., 11, 149, 10.1038/s41419-020-2335-1 · DOI
- Zhao, 2019, Oxid. Med. Cell. Longevity, 2019, 9290728
- Wang, 2018, J. Exp. Clin. Cancer Res., 37, 37, 10.1186/s13046-018-0689-3 · DOI
- Wang, 2020, Biomater. Sci., 8, 4426, 10.1039/D0BM00898B · DOI
- Wang, 2020, Biomater. Sci., 8, 552, 10.1039/C9BM01392J · DOI
- Zhang, 2019, Biomater. Sci., 7, 1962, 10.1039/C9BM00009G · DOI
- Huang, 2020, Biomater. Sci., 8, 2376, 10.1039/D0BM00129E · DOI
- Zhang, 2020, Biomater. Sci., 8, 1885, 10.1039/C9BM01927H · DOI
- Ou, 2019, Biomater. Sci., 7, 2491, 10.1039/C9BM00344D · DOI
- Chen, 2018, Front. Pharmacol., 9, 118, 10.3389/fphar.2018.00118 · DOI
- Zhang, 2019, Biomater. Sci., 7, 4230, 10.1039/C9BM00991D · DOI
- Wu, 2012, Acta Biomater., 8, 4314, 10.1016/j.actbio.2012.07.027 · DOI
- Orsolic, 2020, Oncogene, 39, 3443, 10.1038/s41388-020-1231-6 · DOI
- Montanaro, 2007, Cell Proliferation, 40, 532, 10.1111/j.1365-2184.2007.00448.x · DOI
- Chaudhary, 2019, Biomater. Sci., 7, 5002, 10.1039/C9BM00822E · DOI
- Li, 2018, Chin. Chem. Lett., 29, 1347, 10.1016/j.cclet.2017.11.025 · DOI
- Tian, 2019, Medicine, 98, e15650, 10.1097/MD.0000000000015650 · DOI
Cited by
Sorted by citations
Emerging role of exosomes in cancer therapy: progress and challenges
Li, J., Wang, J., & Chen, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02215-4 · Cited by 297
Metadata
- Authors
- Li, X., Wang, L., Wang, L., Yu, J., Lu, G., Zhao, W., Miao, C., Zou, C., & Wu, J.
- Venue
- Biomaterials Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2020
- Volume
- 8
- Issue
- 21
- Pages
- 5888-5899
- ISSN
- 2047-4830
- 2047-4849
- Cited by
- 28
- References
- 1
- Language
- en
- Funders
- National Natural Science Foundation of China (81972651, 51973243, 31771630)
- National Science and Technology Major Project of the Ministry of Science and Technology of China (2018ZX10301402)
- Natural Science Foundation of Guangdong Province (2017A030312009, 2016A030313238)
- Shanxi Province Science Foundation for Youths (201901D211471)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review